Article
Implications of hematopoietic stem cells heterogeneity for gene therapies
15 Feb 2021
Abstract excerpt
Hematopoietic stem cell transplantation (HSCT) is the therapeutic concept to cure the blood/immune system of patients suffering from malignancies, immunodeficiencies, red blood cell disorders, and inherited bone marrow failure syndromes. Yet, allogeneic HSCT bear considerable risks for the patient such as non-engraftment, or graft-versus host disease. Transplanting gene modified autologous HSCs is a promising...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
